Hinge Health, Inc.
HNGENYSEHealthcare● Active
$64.41
+$0.79(+1.24%)
Market Cap$5.0B
P/E Ratio—
52W High$66.5499
52W Low$30.08
Hinge Health, Inc.（HNGE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HNGE · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 |
|---|---|---|---|
| Revenue | |||
| Revenue | $0.59B | $0.39B | $0.29B |
| Cost of Revenue | $0.12B | $0.09B | $0.10B |
| Gross Profit | $0.47B | $0.30B | $0.19B |
| Gross Margin %(computed) | 79.83% | 77.00% | 66.33% |
| Operating Expenses | |||
| R&D Expenses | $0.37B | $0.10B | $0.11B |
| G&A Expenses | $0.33B | $0.06B | $0.07B |
| Total Operating Expenses | $1.02B | $0.33B | $0.32B |
| Operating Income | ($0.55B) | ($0.03B) | ($0.13B) |
| Operating Margin %(computed) | -92.94% | -8.17% | -44.59% |
| Interest Income | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.53B) | ($0.01B) | ($0.11B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.53B) | ($0.01B) | ($0.11B) |
| Net Margin %(computed) | -89.86% | -3.06% | -36.94% |
| Per Share & EBITDA | |||
| EPS (Basic) | $-5.36 | $-0.15 | $-1.39 |
| Wtd Avg Shares | 0.08B | 0.08B | 0.08B |
| EBITDA | ($0.54B) | ($0.02B) | ($0.13B) |
| EBITDA Margin %(computed) | -91.16% | -5.66% | -43.86% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Hinge Health, Inc.
关于Hinge Health, Inc.（HNGE）损益表
Hinge Health, Inc.（HNGE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，HNGE实现营收$0.59B，毛利润$0.47B（毛利率79.83%），净利润($0.53B)（净利率-89.86%）。
常见问题
HNGE · 4 问Hinge Health, Inc.（HNGE）2025财年营收为$0.59B，同比up50.6%。
HNGE revenueHNGE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08